Daniel Atar

575 total citations · 1 hit paper
7 papers, 265 citations indexed

About

Daniel Atar is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Daniel Atar has authored 7 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Daniel Atar's work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (3 papers) and CRISPR and Genetic Engineering (2 papers). Daniel Atar is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (3 papers) and CRISPR and Genetic Engineering (2 papers). Daniel Atar collaborates with scholars based in Germany, Australia and Latvia. Daniel Atar's co-authors include Christian Seitz, Rupert Handgretinger, Ann‐Christin Pecher, Christoph Faul, Antje Bornemann, Jörg Henes, Patrick Schlegel, Rebekka Schairer, Luca Hensen and Reinhild Klein and has published in prestigious journals such as JAMA, International Journal of Molecular Sciences and Science Translational Medicine.

In The Last Decade

Daniel Atar

7 papers receiving 259 citations

Hit Papers

CD19-Targeting CAR T Cells for Myositis and Interstitial ... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Atar Germany 6 198 121 67 45 38 7 265
Shengkang Huang China 5 210 1.1× 113 0.9× 106 1.6× 51 1.1× 19 0.5× 8 377
Matteo Doglio Italy 8 150 0.8× 116 1.0× 50 0.7× 30 0.7× 10 0.3× 19 245
Sifei Chen China 6 225 1.1× 116 1.0× 111 1.7× 56 1.2× 16 0.4× 13 392
Chengfei Pu China 8 202 1.0× 96 0.8× 87 1.3× 60 1.3× 8 0.2× 19 277
Steven Tsai United States 8 166 0.8× 84 0.7× 151 2.3× 33 0.7× 32 0.8× 14 308
Tiina Hannunen Finland 4 139 0.7× 125 1.0× 100 1.5× 46 1.0× 15 0.4× 4 285
Timothy Voorhees United States 8 152 0.8× 55 0.5× 53 0.8× 32 0.7× 10 0.3× 37 240
Takeya Masubuchi United States 6 186 0.9× 180 1.5× 99 1.5× 30 0.7× 14 0.4× 8 315
Paraskevi Dimou United Kingdom 6 205 1.0× 108 0.9× 87 1.3× 32 0.7× 10 0.3× 8 303
Sean C. Dougherty United States 5 292 1.5× 126 1.0× 118 1.8× 80 1.8× 12 0.3× 14 341

Countries citing papers authored by Daniel Atar

Since Specialization
Citations

This map shows the geographic impact of Daniel Atar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Atar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Atar more than expected).

Fields of papers citing papers by Daniel Atar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Atar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Atar. The network helps show where Daniel Atar may publish in the future.

Co-authorship network of co-authors of Daniel Atar

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Atar. A scholar is included among the top collaborators of Daniel Atar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Atar. Daniel Atar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Zekri, Latifa, Ilona Hagelstein, Melanie Märklin, et al.. (2024). Immunocytokines with target cell–restricted IL-15 activity for treatment of B cell malignancies. Science Translational Medicine. 16(737). eadh1988–eadh1988. 6 indexed citations
2.
Pecher, Ann‐Christin, Luca Hensen, Reinhild Klein, et al.. (2023). CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome. JAMA. 329(24). 2154–2154. 128 indexed citations breakdown →
3.
Schneidawind, Dominik, Susanne S. Renner, Daniel Atar, et al.. (2022). Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(8). 513.e1–513.e4. 4 indexed citations
4.
Atar, Daniel, et al.. (2022). Adapter CAR T Cell Therapy for the Treatment of B-Lineage Lymphomas. Biomedicines. 10(10). 2420–2420. 10 indexed citations
5.
Schleicher, Sabine, Daniel Atar, Christian Seitz, et al.. (2022). Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL. International Journal of Molecular Sciences. 23(21). 12828–12828. 37 indexed citations
6.
Seitz, Christian, Sarah M. Schroeder, Philipp Knopf, et al.. (2019). GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells. OncoImmunology. 9(1). 1683345–1683345. 64 indexed citations
7.
Schlegel, Patrick, Christian Seitz, Daniel Atar, et al.. (2019). CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies. Briefings in Functional Genomics. 19(3). 191–200. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026